최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기초록이 없습니다.
1 American Diabetes Asociation Medical Management of Type 1 Diabetes . Alexandria, VA , American Diabetes Association , 2008
2 American Diabetes Asociation Medical Management of Type 2 Diabetes . Alexandria, VA , American Diabetes Association , 2008
3 American Diabetes Association Intensive Diabetes Management . Alexandria, VA , American Diabetes Association , 2009
4 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Diabetes Care 1997 ; 20 : 1183 ? 1197 9203460
5 International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes . Diabetes Care 2009 ; 32 : 1327 ? 1334 19502545
6 American Diabetes Association Diagnosis and classification of diabetes mellitus . Diabetes Care 2010 ; 33 ( Suppl. 1 ): S62 ? S69 20042775
7 Genuth S Alberti KG Bennett P Buse J Defronzo R Kahn R Kitzmiller J Knowler WC Lebovitz H Lernmark A Nathan D Palmer J Rizza R Saudek C Shaw J Steffes M Stern M Tuomilehto J Zimmet P : Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus . Diabetes Care 2003 ; 26 : 3160 ? 3167 14578255
9 Engelgau MM Narayan KM Herman WH : Screening for type 2 diabetes . Diabetes Care 2000 ; 23 : 1563 ? 1580 11023153
10 Gabir MM Hanson RL Dabelea D Imperatore G Roumain J Bennett PH Knowler WC : The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes . Diabetes Care 2000 ; 23 : 1108 ? 1112 10937506
11 Knowler WC Barrett-Connor E Fowler SE Hamman RF Lachin JM Walker EA Nathan DM : Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin . N Engl J Med 2002 ; 346 : 393 ? 403 11832527
12 Tuomilehto J Lindstrom J Eriksson JG Valle TT Hamalainen H Ilanne-Parikka P Keinanen-Kiukaanniemi S Laakso M Louheranta A Rastas M Salminen V Uusitupa M : Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance . N Engl J Med 2001 ; 344 : 1343 ? 1350 11333990
13 Pan XR Li GW Hu YH Wang JX Yang WY An ZX Hu ZX Lin J Xiao JZ Cao HB Liu PA Jiang XG Jiang YY Wang JP Zheng H Zhang H Bennett PH Howard BV : Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study . Diabetes Care 1997 ; 20 : 537 ? 544 9096977
14 Buchanan TA Xiang AH Peters RK Kjos SL Marroquin A Goico J Ochoa C Tan S Berkowitz K Hodis HN Azen SP : Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women . Diabetes 2002 ; 51 : 2796 ? 2803 12196473
15 Chiasson JL Josse RG Gomis R Hanefeld M Karasik A Laakso M : STOP-NIDDM Trail Research Group Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial . Lancet 2002 ; 359 : 2072 ? 2077 12086760
16 DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators Gerstein HC Yusuf S Bosch J Pogue J Sheridan P Dinccag N Hanefeld M Hoogwerf B Laakso M Mohan V Shaw J Zinman B Holman RR : Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial . Lancet 2006 ; 368 : 1096 ? 1105 16997664
17 Ramachandran A Snehalatha C Mary S Mukesh B Bhaskar AD Vijay V : Indian Diabetes Prevention Programme (IDPP) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) . Diabetologia 2006 ; 49 : 289 ? 297 16391903
18 Johnson SL Tabaei BP Herman WH : The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45?74 years of age . Diabetes Care 2005 ; 28 : 307 ? 311 15677784
19 Harris R Donahue K Rathore SS Frame P Woolf SH Lohr KN : Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force . Ann Intern Med 2003 ; 138 : 215 ? 229 12558362
20 U.S. Preventive Services Task Force. S. Preventive Services Task Force. S. Preventive Services Task Force : Screening for type 2 diabetes mellitus in adults: recommendations and rationale . Ann Intern Med 2003 ; 138 : 212 ? 214 12558361
21 Writing Group for the SEARCH for Diabetes in Youth Study Group Dabelea D Bell RA D'Agostino RB Jr Imperatore G Johansen JM Linder B Liu LL Loots B Marcovina S Mayer-Davis EJ Pettitt DJ Waitzfelder B : Incidence of diabetes in youth in the United States . JAMA 2007 ; 297 : 2716 ? 2724 17595272
22 SEARCH for Diabetes in Youth Study Group Liese AD D'Agostino RB Jr Hamman RF Kilgo PD Lawrence JM Liu LL Loots B Linder B Marcovina S Rodriguez B Standiford D Williams DE : The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study . Pediatrics 2006 ; 118 : 1510 ? 1518 17015542
23 American Diabetes Association : Type 2 diabetes in children and adolescents (Consensus Statement) . Diabetes Care 2000 ; 23 : 381 ? 389 10868870
24 Lawrence JM Contreras R Chen W Sacks DA : Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999?2005 . Diabetes Care 2008 ; 31 : 899 ? 904 18223030
25 American Diabetes Association : Gestational diabetes mellitus (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S88 ? S90 14693936
26 HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA : Hyperglycemia and adverse pregnancy outcomes . N Engl J Med 2008 ; 358 : 1991 ? 2002 18463375
27 Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB : Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network A multicenter, randomized trial of treatment for mild gestational diabetes . N Engl J Med 2009 ; 361 : 1339 ? 1348 19797280
28 Kim C Newton KM Knopp RH : Gestational diabetes and the incidence of type 2 diabetes: a systematic review . Diabetes Care 2002 ; 25 : 1862 ? 1868 12351492
29 Lindstrom J Ilanne-Parikka P Peltonen M Aunola S Eriksson JG Hemio K Hamalainen H Harkonen P Keinanen-Kiukaanniemi S Laakso M Louheranta A Mannelin M Paturi M Sundvall J Valle TT Uusitupa M Tuomilehto J : Finnish Diabetes Prevention Study Group Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study . Lancet 2006 ; 368 : 1673 ? 1679 17098085
30 Li G Zhang P Wang J Gregg EW Yang W Gong Q Li H Li H Jiang Y An Y Shuai Y Zhang B Zhang J Thompson TJ Gerzoff RB Roglic G Hu Y Bennett PH : The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study . Lancet 2008 ; 371 : 1783 ? 1789 18502303
31 Kosaka K Noda M Kuzuya T : Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males . Diabetes Res Clin Pract 2005 ; 67 : 152 ? 162 15649575
32 Torgerson JS Hauptman J Boldrin MN Sjostrom L : XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients . Diabetes Care 2004 ; 27 : 155 ? 161 14693982
33 Kawamori R Tajima N Iwamoto Y Kashiwagi A Shimamoto K Kaku K : Voglibose Ph-3 Study Group Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance . Lancet 2009 ; 373 : 1607 ? 1614 19395079
34 De Fronzo RA : for ACT NOW Study Group ACTos NOW Study for the Prevention of Diabetes (ACT NOW) Study . Late-breaking abstract presented at 68th Annual Scientific Sessions of the American Diabetes Association , 6 June 2008 , San Francisco, CA
35 Gerstein HC : Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach . Diabetes Care 2007 ; 30 : 432 ? 434 17259525
36 Nathan DM Davidson MB DeFronzo RA Heine RJ Henry RR Pratley R Zinman B : American Diabetes Association Impaired fasting glucose and impaired glucose tolerance: implications for care . Diabetes Care 2007 ; 30 : 753 ? 759 17327355
37 American Diabetes Association : Consensus statement on self-monitoring of blood glucose . Diabetes Care 1987 ; 10 : 95 ? 99 3552518
38 American Diabetes Association : Self-monitoring of blood glucose . Diabetes Care 1994 ; 17 : 81 ? 86 8112195
39 Welschen LM Bloemendal E Nijpels G Dekker JM Heine RJ Stalman WA Bouter LM : Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review . Diabetes Care 2005 ; 28 : 1510 ? 1517 15920083
40 Farmer A Wade A Goyder E Yudkin P French D Craven A Holman R Kinmonth AL Neil A : Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial . BMJ 2007 ; 335 : 132 17591623
41 O'Kane MJ Bunting B Copeland M Coates VE : ESMON study group Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial . BMJ 2008 ; 336 : 1174 ? 1177 18420662
42 Simon J Gray A Clarke P Wade A Neil A Farmer A : Diabetes Glycaemic Education and Monitoring Trial Group Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial . BMJ 2008 ; 336 : 1177 ? 1180 18420663
43 Sacks DB Bruns DE Goldstein DE Maclaren NK McDonald JM Parrott M : Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus . Clin Chem 2002 ; 48 : 436 ? 472 11861436
44 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group Tamborlane WV Beck RW Bode BW Buckingham B Chase HP Clemons R Fiallo-Scharer R Fox LA Gilliam LK Hirsch IB Huang ES Kollman C Kowalski AJ Laffel L Lawrence JM Lee J Mauras N O'Grady M Ruedy KJ Tansey M Tsalikian E Weinzimer S Wilson DM Wolpert H Wysocki T Xing D : Continuous glucose monitoring and intensive treatment of type 1 diabetes . N Engl J Med 2008 ; 359 : 1464 ? 1476 18779236
45 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group : The effect of continuous glucose monitoring in well-controlled type 1 diabetes . Diabetes Care 2009 ; 32 : 1378 ? 1383 19429875
46 Stratton IM Adler AI Neil HA Matthews DR Manley SE Cull CA Hadden D Turner RC Holman RR : Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study . BMJ 2000 ; 321 : 405 ? 412 10938048
47 Cagliero E Levina EV Nathan DM : Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients . Diabetes Care 1999 ; 22 : 1785 ? 1789 10546008
48 Miller CD Barnes CS Phillips LS Ziemer DC Gallina DL Cook CB Maryman SD El-Kebbi IM : Rapid A1c availability improves clinical decision-making in an urban primary care clinic . Diabetes Care 2003 ; 26 : 1158 ? 1163 12663590
49 Nathan DM Kuenen J Borg R Zheng H Schoenfeld D Heine RJ : A1c-Derived Average Glucose Study Group Translating the A1C assay into estimated average glucose values . Diabetes Care 2008 ; 31 : 1473 ? 1478 18540046
50 Rohlfing CL Wiedmeyer HM Little RR England JD Tennill A Goldstein DE : Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial . Diabetes Care 2002 ; 25 : 275 ? 278 11815495
51 Diabetes Research in Children Network (DirecNet) Study Group Wilson DM Kollman : Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors . Diabetes Care 2008 ; 31 : 381 ? 385 18056888
52 Skyler JS Bergenstal R Bonow RO Buse J Deedwania P Gale EA Howard BV Kirkman MS Kosiborod M Reaven P Sherwin RS : American Diabetes Association, American College of Cardiology Foundation, American Heart Association Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association . Diabetes Care 2009 ; 32 : 187 ? 192 19092168
53 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group . N Engl J Med 1993 ; 329 : 977 ? 986 8366922
54 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group . N Engl J Med 2000 ; 342 : 381 ? 389 10666428
55 Martin CL Albers J Herman WH Cleary P Waberski B Greene DA Stevens MJ Feldman EL : DCCT/EDIC Research Group Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion . Diabetes Care 2006 ; 29 : 340 ? 344 16443884
56 Ohkubo Y Kishikawa H Araki E Miyata T Isami S Motoyoshi S Kojima Y Furuyoshi N Shichiri M : Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study . Diabetes Res Clin Pract 1995 ; 28 : 103 ? 117 7587918
57 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34): UK Prospective Diabetes Study (UKPDS) Group . Lancet 1998 ; 352 : 854 ? 865 9742977
58 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group . Lancet 1998 ; 352 : 837 ? 853 9742976
59 Holman RR Paul SK Bethel MA Matthews DR Neil HA : 10-Year follow-up of intensive glucose control in type 2 diabetes . N Engl J Med 2008 ; 359 : 1577 ? 1589 18784090
60 Duckworth W Abraira C Moritz T Reda D Emanuele N Reaven PD Zieve FJ Marks J Davis SN Hayward R Warren SR Goldman S McCarren M Vitek ME Henderson WG Huang GD : VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes . N Engl J Med 2009 ; 360 : 129 ? 139 19092145
61 Moritz T Duckworth W Abraira C : Veterans Affairs diabetes trial?corrections . N Engl J Med 2009 ; 361 : 1024 ? 1025 19726779
62 Lawson ML Gerstein HC Tsui E Zinman B : Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: A systematic review and meta-analysis . Diabetes Care 1999 ; 22 ( Suppl. 2 ): B35 ? B39 10097897
63 ADVANCE Collaborative Group Patel A MacMahon S Chalmers J Neal B Billot L Woodward M Marre M Cooper M Glasziou P Grobbee D Hamet P Harrap S Heller S Liu L Mancia G Mogensen CE Pan C Poulter N Rodgers A Williams B Bompoint S de Galan BE Joshi R Travert F : Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes . N Engl J Med 2008 ; 358 : 2560 ? 2572 18539916
64 Selvin E Marinopoulos S Berkenblit G Rami T Brancati FL Powe NR Golden SH : Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus . Ann Intern Med 2004 ; 141 : 421 ? 431 15381515
65 Stettler C Allemann S Juni P Cull CA Holman RR Egger M Krahenbuhl S Diem P : Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials . Am Heart J 2006 ; 152 : 27 ? 38 16824829
66 Nathan DM Cleary PA Backlund JY Genuth SM Lachin JM Orchard TJ Raskin P Zinman B : Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes . N Engl J Med 2005 ; 353 : 2643 ? 2653 16371630
67 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group Nathan DM Zinman B Cleary PA Backlund JY Genuth S Miller R Orchard TJ : Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983?2005) . Arch Intern Med 2009 ; 169 : 1307 ? 1316 19636033
68 Action to Control Cardiovascular Risk in Diabetes Study Group Gerstein HC Miller ME Byington RP Goff DC Jr Bigger JT Buse JB Cushman WC Genuth S Ismail-Beigi F Grimm RH Jr Probstfield JL Simons-Morton DG Friedewald WT : Effects of intensive glucose lowering in type 2 diabetes . N Engl J Med 2008 ; 358 : 2545 ? 2559 18539917
69 Duckworth W : VADT Results . Late-breaking abstract presented at 68th Annual Scientific Sessions of the American Diabetes Association , 6 June 2008 , San Francisco, CA
70 Reaven PD Moritz TE Schwenke DC Anderson RJ Criqui M Detrano R Emanuele N Kayshap M Marks J Mudaliar S Rao RH Shah JH Goldman S Reda DJ McCarren M Abraira C Duckworth W : Intensive glucose lowering therapy reduces cardiovascular disease events in VADT participants with lower calcified coronary atherosclerosis . Diabetes 2009 ; 59 : 2642 ? 2648 19651816
71 Turnbull FM Abraira C Anderson RJ Byington RP Chalmers JP Duckworth WC Evans GW Gerstein HC Holman RR Moritz TE Neal BC Ninomiya T Patel AA Paul SK Travert F Woodward M : Intensive glucose control and macrovascular outcomes in type 2 diabetes . Diabetologia 2009 ; 52 : 2288 ? 2298 19655124
72 American Diabetes Association : Postprandial blood glucose (Consensus Statement) . Diabetes Care 2001 ; 24 : 775 ? 778 11315848
73 Ceriello A Taboga C Tonutti L Quagliaro L Piconi L Bais B Da Ros R Motz E : Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment . Circulation 2002 ; 106 : 1211 ? 1218 12208795
74 Raz I Wilson PW Strojek K Kowalska I Bozikov V Gitt AK Jermendy G Campaigne BN Kerr L Milicevic Z Jacober SJ : Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial . Diabetes Care 2009 ; 32 : 381 ? 386 19246588
75 Metzger BE Buchanan TA Coustan DR de Leiva A Dunger DB Hadden DR Hod M Kitzmiller JL Kjos SL Oats JN Pettitt DJ Sacks DA Zoupas C : Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus . Diabetes Care 2007 ; 30 ( Suppl. 2 ): S251 ? S260 17596481
76 Kitzmiller JL Block JM Brown FM Catalano PM Conway DL Coustan DR Gunderson EP Herman WH Hoffman LD Inturrisi M Jovanovic LB Kjos SI Knopp RH Montoro MN Ogata ES Paramsothy P Reader DM Rosenn BM Thomas AM Kirkman MS : Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care . Diabetes Care 2008 ; 31 : 1060 ? 1079 18445730
77 DeWitt DE Hirsch IB : Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review . JAMA 2003 ; 289 : 2254 ? 2264 12734137
78 Rosenstock J Dailey G Massi-Benedetti M Fritsche A Lin Z Salzman A : Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes . Diabetes Care 2005 ; 28 : 950 ? 955 15793205
79 Mooradian AD Bernbaum M Albert SG : Narrative review: a rational approach to starting insulin therapy . Ann Intern Med 2006 ; 145 : 125 ? 134 16847295
80 Nathan DM Buse JB Davidson MB Heine RJ Holman RR Sherwin R Zinman B : Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes . Diabetes Care 2006 ; 29 : 1963 ? 1972 16873813
81 Nathan DM Buse JB Davidson MB Ferrannini E Holman RR Sherwin R Zinman B : American Diabetes Association, European Association for Study of Diabetes Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes . Diabetes Care 2009 ; 32 : 193 ? 203 18945920
82 Bantle JP Wylie-Rosett J Albright AL Apovian CM Clark NG Franz MJ Hoogwerf BJ Lichtenstein AH Mayer-Davis E Mooradian AD Wheeler ML : Nutrition recommendations and interventions for diabetes―2006 . Diabetes Care 2006 ; 29 : 2140 ? 2157 16936169
83 DAFNE Study Group Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial . BMJ 2002 ; 325 : 746 12364302
84 Franz MJ Monk A Barry B McClain K Weaver T Cooper N Upham P Bergenstal R Mazze RS : Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial . J Am Diet Assoc 1995 ; 95 : 1009 ? 1017 7657902
85 Goldhaber-Fiebert JD Goldhaber-Fiebert SN Tristan ML Nathan DM : Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica . Diabetes Care 2003 ; 26 : 24 ? 29 12502654
86 Lemon CC Lacey K Lohse B Hubacher DO Klawitter B Palta M : Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes . J Am Diet Assoc 2004 ; 104 : 1805 ? 1815 15565074
87 Miller CK Edwards L Kissling G Sanville L : Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial . Prev Med 2002 ; 34 : 252 ? 259 11817922
88 Wilson C Brown T Acton K Gilliland S : Effects of clinical nutrition education and educator discipline on glycemic control outcomes in the Indian health service . Diabetes Care 2003 ; 26 : 2500 ? 2504 12941709
89 Graber AL Elasy TA Quinn D Wolff K Brown A : Improving glycemic control in adults with diabetes mellitus: shared responsibility in primary care practices . South Med J 2002 ; 95 : 684 ? 690 12144072
90 Gaetke LM Stuart MA Truszczynska H : A single nutrition counseling session with a registered dietitian improves short-term clinical outcomes for rural Kentucky patients with chronic diseases . J Am Diet Assoc 2006 ; 106 : 109 ? 112 16390674
91 Yu-Poth S Zhao G Etherton T Naglak M Jonnalagadda S Kris-Etherton PM : Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis . Am J Clin Nutr 1999 ; 69 : 632 ? 646 10197564
92 Van Horn L McCoin M Kris-Etherton PM Burke F Carson JA Champagne CM Karmally W Sikand G : The evidence for dietary prevention and treatment of cardiovascular disease . J Am Diet Assoc 2008 ; 108 : 287 ? 331 18237578
93 Appel LJ Moore TJ Obarzanek E Vollmer WM Svetkey LP Sacks FM Bray GA Vogt TM Cutler JA Windhauser MM Lin PH Karanja N : A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group . N Engl J Med 1997 ; 336 : 1117 ? 1124 9099655
94 Norris SL Zhang X Avenell A Gregg E Bowman B Schmid CH Lau J : Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review . Am J Prev Med 2005 ; 28 : 126 ? 139 15626569
95 Klein S Sheard NF Pi-Sunyer X Daly A Wylie-Rosett J Kulkarni K Clark NG : American Diabetes Association, North American Association for the Study of Obesity, American Society for Clinical Nutrition Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition . Diabetes Care 2004 ; 27 : 2067 ? 2073 15277443
96 Norris SL Zhang X Avenell A Gregg E Schmid CH Kim C Lau J : Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis . Arch Intern Med 2004 ; 164 : 1395 ? 1404 15249348
97 Wolf AM Conaway MR Crowther JQ Hazen KY L Nadler J Oneida B Bovbjerg VE : Improving Control with Activity and Nutrition (ICAN) Study Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study . Diabetes Care 2004 ; 27 : 1570 ? 1576 15220230
98 Manning RM Jung RT Leese GP Newton RW : The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four-year follow-up . Diabet Med 1998 ; 15 : 497 ? 502 9632125
99 Shai I Schwarzfuchs D Henkin Y Shahar DR Witkow S Greenberg I Golan R Fraser D Bolotin A Vardi H Tangi-Rozental O Zuk-Ramot R Sarusi B Brickner D Schwartz Z Sheiner E Marko R Katorza E Thiery J Fiedler GM Bluher M Stumvoll M Stampfer MJ : Dietary Intervention Randomized Controlled Trial (DIRECT) Group Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet . N Engl J Med 2008 ; 359 : 229 ? 241 18635428
100 Franz MJ VanWormer JJ Crain AL Boucher JL Histon T Caplan W Bowman JD Pronk NP : Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up . J Am Diet Assoc 2007 ; 107 : 1755 ? 1767 17904936
101 Look AHEAD Research Group Pi-Sunyer X Blackburn G Brancati FL Bray GA Bright R Clark JM Curtis JM Espeland MA Foreyt JP Graves K Haffner SM Harrison B Hill JO Horton ES Jakicic J Jeffery RW Johnson KC Kahn S Kelley DE Kitabchi AE Knowler WC Lewis CE Maschak-Carey BJ Montgomery B Nathan DM Patricio J Peters A Redmon JB Reeves RS Ryan DH Safford M Van Dorsten B Wadden TA Wagenknecht L Wesche-Thobaben J Wing RR Yanovski SZ : Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial . Diabetes Care 2007 ; 30 : 1374 ? 1383 17363746
102 Foster GD Wyatt HR Hill JO McGuckin BG Brill C Mohammed BS Szapary PO Rader DJ Edman JS Klein S : A randomized trial of a low-carbohydrate diet for obesity . N Engl J Med 2003 ; 348 : 2082 ? 2090 12761365
103 Stern L Iqbal N Seshadri P Chicano KL Daily DA McGrory J Williams M Gracely EJ Samaha FF : The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial . Ann Intern Med 2004 ; 140 : 778 ? 785 15148064
104 Gardner CD Kiazand A Alhassan S Kim S Stafford RS Balise RR Kraemer HC King AC : Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women . JAMA 2007 ; 297 : 969 ? 977 17341711
105 Nordmann AJ Nordmann A Briel M Keller U Yancy WS Jr Brehm BJ Bucher HC : Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials . Arch Intern Med 2006 ; 166 : 285 ? 293 16476868
106 Institute of Medicine : DIetary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids . Washington, DC , National Academies Press , 2002
107 Barnard ND Cohen J Jenkins DJ Turner-McGrievy G Gloede L Jaster B Seidl K Green AA Talpers S : A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes . Diabetes Care 2006 ; 29 : 1777 ? 1783 16873779
108 Turner-McGrievy GM Barnard ND Cohen J Jenkins DJ Gloede L Green AA : Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks . J Am Diet Assoc 2008 ; 108 : 1636 ? 1645 18926128
109 Franz MJ Bantle JP Beebe CA Brunzell JD Chiasson JL Garg A Holzmeister LA Hoogwerf B Mayer-Davis E Mooradian AD Purnell JQ Wheeler M : Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications . Diabetes Care 2002 ; 25 : 148 ? 198 11772915
110 Buchwald H Estok R Fahrbach K Banel D Jensen MD Pories WJ Bantle JP Sledge I : Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis . Am J Med 2009 ; 122 : 248 ? 256 19272486
111 Dixon JB O'Brien PE Playfair J Chapman L Schachter LM Skinner S Proietto J Bailey M Anderson M : Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial . JAMA 2008 ; 299 : 316 ? 323 18212316
112 Buchwald H Estok R Fahrbach K Banel D Sledge I : Trends in mortality in bariatric surgery: a systematic review and meta-analysis . Surgery 2007 ; 142 : 621 ? 632 17950357
113 Sjostrom L Narbro K Sjostrom CD Karason K Larsson B Wedel H Lystig T Sullivan M Bouchard C Carlsson B Bengtsson C Dahlgren S Gummesson A Jacobson P Karlsson J Lindroos AK Lonroth H Naslund I Olbers T Stenlof K Torgerson J Agren G Carlsson LM : Swedish Obese Subjects Study Effects of bariatric surgery on mortality in Swedish obese subjects . N Engl J Med 2007 ; 357 : 741 ? 752 17715408
114 Piette JD Glasgow RE : Sttategies for improving behavioral and health outcomes among people with diabetes: self management education . In Evidence-Based Diabetes Care . Gerstein HC Hayes RB : Eds. Ontario, Canada, BC Decker , 2000
115 Norris SL Engelgau MM Narayan KM : Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials . Diabetes Care 2001 ; 24 : 561 ? 587 11289485
116 Norris SL Lau J Smith SJ Schmid CH Engelgau MM : Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control . Diabetes Care 2002 ; 25 : 1159 ? 1171 12087014
117 Gary TL Genkinger JM Guallar E Peyrot M Brancati FL : Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes . Diabetes Educ 2003 ; 29 : 488 ? 501 12854339
118 Steed L Cooke D Newman S : A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus . Patient Educ Couns 2003 ; 51 : 5 ? 15 12915275
119 Ellis SE Speroff T Dittus RS Brown A Pichert JW Elasy TA : Diabetes patient education: a meta-analysis and meta-regression . Patient Educ Couns 2004 ; 52 : 97 ? 105 14729296
120 Warsi A Wang PS LaValley MP Avorn J Solomon DH : Self-management education programs in chronic disease: a systematic review and methodological critique of the literature . Arch Intern Med 2004 ; 164 : 1641 ? 1649 15302634
121 Funnell MM Brown TL Childs BP Haas LB Hosey GM Jensen B Maryniuk M Peyrot M Piette JD Reader D Siminerio LM Weinger K Weiss MA : National standards for diabetes self-management education . Diabetes Care 2007 ; 30 : 1630 ? 1637 17526822
122 Mulcahy K Maryniuk M Peeples M Peyrot M Tomky D Weaver T Yarborough P : Diabetes self-management education core outcomes measures . Diabetes Educ 29 : 768- 2003 ; 84 : 787 14603868
123 Glasgow RE Peeples M Skovlund SE : Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures . Diabetes Care 2008 ; 31 : 1046 ? 1050 18445728
124 Barker JM Goehrig SH Barriga K Hoffman M Slover R Eisenbarth GS Norris JM Klingensmith GJ Rewers M : DAISY study Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up . Diabetes Care 2004 ; 27 : 1399 ? 1404 15161795
125 Cochran J Conn VS : Meta-analysis of quality of life outcomes following diabetes self-management training . Diabetes Educ 2008 ; 34 : 815 ? 823 18832286
126 Fisher EB Thorpe CT Devellis BM Devellis RF : Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal . Diabetes Educ 2007 ; 33 : 1080 ? 1103 18057276
127 Robbins JM Thatcher GE Webb DA Valdmanis VG : Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study . Diabetes Care 2008 ; 31 : 655 ? 660 18184894
128 Renders CM Valk GD Griffin SJ Wagner EH Eijk Van JT Assendelft WJ : Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review . Diabetes Care 2001 ; 24 : 1821 ? 1833 11574449
129 Polonsky WH Earles J Smith S Pease DJ Macmillan M Christensen R Taylor T Dickert J Jackson RA : Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program . Diabetes Care 2003 ; 26 : 3048 ? 3053 14578238
130 Anderson RM Funnell MM Nwankwo R Gillard ML Oh M Fitzgerald JT : Evaluating a problem-based empowerment program for African Americans with diabetes: results of a randomized controlled trial . Ethn Dis 2005 ; 15 : 671 ? 678 16259492
131 Brown SA Blozis SA Kouzekanani K Garcia AA Winchell M Hanis CL : Dosage effects of diabetes self-management education for Mexican Americans: the Starr County Border Health Initiative . Diabetes Care 2005 ; 28 : 527 ? 532 15735182
132 Glazier RH Bajcar J Kennie NR Willson K : A systematic review of interventions to improve diabetes care in socially disadvantaged populations . Diabetes Care 2006 ; 29 : 1675 ? 1688 16801602
133 Sarkisian CA Brown AF Norris KC Wintz RL Mangione CM : A systematic review of diabetes self-care interventions for older, African American, or Latino adults . Diabetes Educ 2003 ; 29 : 467 ? 479 12861963
134 Chodosh J Morton SC Mojica W Maglione M Suttorp MJ Hilton L Rhodes S Shekelle P : Meta-analysis: chronic disease self-management programs for older adults . Ann Intern Med 2005 ; 143 : 427 ? 438 16172441
135 Peyrot M Rubin RR : Behavioral and psychosocial interventions in diabetes: a conceptual review . Diabetes Care 2007 ; 30 : 2433 ? 2440 17666457
136 Rickheim PL Weaver TW Flader JL Kendall DM : Assessment of group versus individual diabetes education: a randomized study . Diabetes Care 2002 ; 25 : 269 ? 274 11815494
137 Trento M Passera P Borgo E Tomalino M Bajardi M Cavallo F Porta M : A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care . Diabetes Care 2004 ; 27 : 670 ? 675 14988283
138 Deakin T McShane CE Cade JE Williams RD : Group based training for self-management strategies in people with type 2 diabetes mellitus . Cochrane Database Syst Rev CD003417 , 2005
139 Heisler M : Building Peer Support Programs to Manage Chronic Disease: Seven Models for Success . Oakland, CA , California Health Care Foundation , 2006
140 Foster G Taylor SJ Eldridge SE Ramsay J Griffiths CJ : Self-management education programmes by lay leaders for people with chronic conditions . Cochrane Database Syst Rev CD005108 , 2007
141 Norris SL Chowdhury FM Van Le K Horsley T Brownstein JN Zhang X Jack L Jr Satterfield DW : Effectiveness of community health workers in the care of persons with diabetes . Diabet Med 2006 ; 23 : 544 ? 556 16681564
142 Duncan I Birkmeyer C Coughlin S Li QE Sherr D Boren S : Assessing the value of diabetes education . Diabetes Educ 2009 ; 35 : 752 ? 760 19783766
143 Sigal RJ Kenny GP Wasserman DH Castaneda-Sceppa C : Physical activity/exercise and type 2 diabetes . Diabetes Care 2004 ; 27 : 2518 ? 2539 15451933
144 Wasserman DH Zinman B : Exercise in individuals with IDDM . Diabetes Care 1994 ; 17 : 924 ? 937 7956645
145 Boule NG Haddad E Kenny GP Wells GA Sigal RJ : Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials . JAMA 2001 ; 286 : 1218 ? 1227 11559268
146 Boule NG Kenny GP Haddad E Wells GA Sigal RJ : Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus . Diabetologia 2003 ; 46 : 1071 ? 1081 12856082
147 U.S. Department of Health and Human Services 2008 Physical Activity Guidelines for Americans . Atlanta, GA , Centers for Disease Control and Prevention , 2008
148 Cauza E Hanusch-Enserer U Strasser B Ludvik B Metz-Schimmerl S Pacini G Wagner O Georg P Prager R Kostner K Dunky A Haber P : The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus . Arch Phys Med Rehabil 2005 ; 86 : 1527 ? 1533 16084803
149 Dunstan DW Daly RM Owen N Jolley D De Courten M Shaw J Zimmet P : High-intensity resistance training improves glycemic control in older patients with type 2 diabetes . Diabetes Care 2002 ; 25 : 1729 ? 1736 12351469
150 Castaneda C Layne JE Munoz-Orians L Gordon PL Walsmith J Foldvari M Roubenoff R Tucker KL Nelson ME : A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes . Diabetes Care 2002 ; 25 : 2335 ? 2341 12453982
151 Sigal RJ Kenny GP Boule NG Wells GA Prud'homme D Fortier M Reid RD Tulloch H Coyle D Phillips P Jennings A Jaffey J : Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial . Ann Intern Med 2007 ; 147 : 357 ? 369 17876019
152 Bax JJ Young LH Frye RL Bonow RO Steinberg HO Barrett EJ : ADA Screening for coronary artery disease in patients with diabetes . Diabetes Care 2007 ; 30 : 2729 ? 2736 17901530
153 Berger M Berchtold P Cuppers HJ Drost H Kley HK Muller WA Wiegelmann W Zimmerman-Telschow H Gries FA Kruskemper HL Zimmermann H : Metabolic and hormonal effects of muscular exercise in juvenile type diabetics . Diabetologia 1977 ; 13 : 355 ? 365 410693
154 American Diabetes Association : Physical activity/exercise and diabetes (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S58 ? S62 14693927
155 Berger M : Adjustment of insulin and oral agent therapy . In Handbook of Exercise in Diabetes . 2nd ed. Ruderman N Devlin JTSSH Krisska A : Eds. Alexandria, VA , American Diabetes Association , 2002 , p. 365 ? 376
156 Aiello LP Wong J Cavallerano J Bursell SE Aiello LM : Retinopathy . In Handbook of Exercise in Diabetes . 2nd ed. Ruderman N Devlin JT Kriska A : Eds. Alexandria, VA , American Diabetes Association , 2002 , p. 401 ? 413
157 Lemaster JW Reiber GE Smith DG Heagerty PJ Wallace C : Daily weight-bearing activity does not increase the risk of diabetic foot ulcers . Med Sci Sports Exerc 2003 ; 35 : 1093 ? 1099 12840628
158 Vinik A Erbas T : Neuropathy . In Handbook of Exercise in Diabetes . 2nd ed. Ruderman N Devlin JT Kriska A : Eds. Alexandria, VA , American Diabetes Association , 2002 , p. 463 ? 496
159 Wackers FJ Young LH Inzucchi SE Chyun DA Davey JA Barrett EJ Taillefer R Wittlin SD Heller GV Filipchuk N Engel S Ratner RE Iskandrian AE : Detection of Ischemia in Asymptomatic Diabetics Investigators Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study . Diabetes Care 2004 ; 27 : 1954 ? 1961 15277423
160 Valensi P Sachs RN Harfouche B Lormeau B Paries J Cosson E Paycha F Leutenegger M Attali JR : Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia . Diabetes Care 2001 ; 24 : 339 ? 343 11213889
161 Mogensen CE : Nephropathy . In Handbook of Exercise in Diabetes . 2nd ed. Ruderman N Devlin JT Kriska A : Eds. Alexandria, VA , American Diabetes Association , 2002 , p. 433 ? 449
162 Anderson RJ Grigsby AB Freedland KE de Groot M McGill JB Clouse RE Lustman PJ : Anxiety and poor glycemic control: a meta-analytic review of the literature . Int J Psychiatry Med 2002 ; 32 : 235 ? 247 12489699
163 Delahanty LM Grant RW Wittenberg E Bosch JL Wexler DJ Cagliero E Meigs JB : Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes . Diabet Med 2007 ; 24 : 48 ? 54 17227324
164 American Diabetes Association : Psychosocial factors affecting adherence, quality of life, and well-being: Helping Patients cope . In Medical Management of Type 1 Diabetes . 5 ed. Francine R Kaufman : Ed. Alexandria, VA , American Diabetes Association , 2008 , p. 173 ? 193
165 Fisher L Skaff MM Mullan JT Arean P Mohr D Masharani U Glasgow R Laurencin G : Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics . Diabetes Care 2007 ; 30 : 542 ? 548 17327318
166 Surwit RS Schneider MS Feinglos MN : Stress and diabetes mellitus . Diabetes Care 1992 ; 15 : 1413 ? 1422 1425110
167 McCulloch DK Glasgow RE Hampson SE Wagner E : A systematic approach to diabetes management in the post-DCCT era . Diabetes Care 1994 ; 17 : 765 ? 769 7924791
168 Rubin RR Peyrot M : Psychological issues and treatments for people with diabetes . J Clin Psychol 2001 ; 57 : 457 ? 478 11255202
169 Jacobson AM : Depression and diabetes . Diabetes Care 1993 ; 16 : 1621 ? 1623 8299460
170 Lustman PJ Griffith LS Clouse RE Cryer PE : Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control . J Nerv Ment Dis 1986 ; 174 : 736 ? 742 3783141
171 Blonde L Merilainen M Karwe V Raskin P : TITRATE Study Group Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets -the TITRATE study . Diabetes Obes Metab 2009 ; 11 : 623 ? 631 19515182
172 American Diabetes Association : Hyperglycemic crises in diabetes . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S94 ? S102 14693938
173 Kitabchi AE Umpierrez GE Miles JM Fisher JN : Hyperglycemic crises in adult patients with diabetes . Diabetes Care 2009 ; 32 : 1335 ? 1343 19564476
174 Cryer PE : Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes . Diabetologia 2002 ; 45 : 937 ? 948 12136392
175 Gannon MC Nuttall FQ : Protein and Diabetes . In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes . Franz MJ Bantle JP : Eds. Alexandria, VA , American Diabetes Association , 1999 , p. 107 ? 125
176 Cryer PE : Diverse causes of hypoglycemia-associated autonomic failure in diabetes . N Engl J Med 2004 ; 350 : 2272 ? 2279 15163777
177 Cryer PE Davis SN Shamoon H : Hypoglycemia in diabetes . Diabetes Care 2003 ; 26 : 1902 ? 1912 12766131
178 Smith SA Poland GA : Use of influenza and pneumococcal vaccines in people with diabetes . Diabetes Care 2000 ; 23 : 95 ? 108 10857977
179 Colquhoun AJ Nicholson KG Botha JL Raymond NT : Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes . Epidemiol Infect 1997 ; 119 : 335 ? 341 9440437
180 Bridges CB Fukuda K Uyeki TM Cox NJ Singleton JA : Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR Recomm Rep 2002 ; 51 : 1 ? 31 12002171
181 American Diabetes Association : Influenza and pneumococcal immunization in diabetes (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S111 ? S113 14693944
182 Gaede P Lund-Andersen H Parving HH Pedersen O : Effect of a multifactorial intervention on mortality in type 2 diabetes . N Engl J Med 2008 ; 358 : 580 ? 591 18256393
183 Buse JB Ginsberg HN Bakris GL Clark NG Costa F Eckel R Fonseca V Gerstein HC Grundy S Nesto RW Pignone MP Plutzky J Porte D Redberg R Stitzel KF Stone NJ : American Heart Association, American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association . Diabetes Care 2007 ; 30 : 162 ? 172 17192355
184 Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Jones DW Materson BJ Oparil S Wright JT Jr Roccella EJ : National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report . JAMA 2003 ; 289 : 2560 ? 2572 12748199
185 Bobrie G Chatellier G Genes N Clerson P Vaur L Vaisse B Menard J Mallion JM : Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients . JAMA 2004 ; 291 : 1342 ? 1349 15026401
186 Sega R Facchetti R Bombelli M Cesana G Corrao G Grassi G Mancia G : Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study . Circulation 2005 ; 111 : 1777 ? 1783 15809377
187 UKPDS : Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group . BMJ 1998 ; 317 : 703 ? 713 9732337
188 Hansson L Zanchetti A Carruthers SG Dahlof B Elmfeldt D Julius S Menard J Rahn KH Wedel H Westerling S : Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group . Lancet 1998 ; 351 : 1755 ? 1762 9635947
189 Adler AI Stratton IM Neil HA Yudkin JS Matthews DR Cull CA Wright AD Turner RC Holman RR : Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study . BMJ 2000 ; 321 : 412 ? 419 10938049
190 Lewington S Clarke R Qizilbash N Peto R Collins R : Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies . Lancet 2002 ; 360 : 1903 ? 1913 12493255
191 Stamler J Vaccaro O Neaton JD Wentworth D : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial . Diabetes Care 1993 ; 16 : 434 ? 444 8432214
192 Cushman WC Grimm RH Jr Cutler JA Evans GW Capes S Corson MA Sadler LS Alderman MH Peterson K Bertoni A Basile JN : ACCORD Study Group : Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial . Am J Cardiol 2007 ; 99 : 44i ? 55i
193 Sacks FM Svetkey LP Vollmer WM Appel LJ Bray GA Harsha D Obarzanek E Conlin PR Miller ER 3rd Simons-Morton DG Karanja N Lin PH : DASH-Sodium Collaborative Research Group Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group . N Engl J Med 2001 ; 344 : 3 ? 10 11136953
194 Tatti P Pahor M Byington RP Di Mauro P Guarisco R Strollo G Strollo F : Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM . Diabetes Care 1998 ; 21 : 597 ? 603 9571349
195 Estacio RO Jeffers BW Hiatt WR Biggerstaff SL Gifford N Schrier RW : The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension . N Engl J Med 1998 ; 338 : 645 ? 652 9486993
196 Schrier RW Estacio RO Mehler PS Hiatt WR : Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial . Nat Clin Pract Nephrol 2007 ; 3 : 428 ? 438 17653121
197 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) . JAMA 2002 ; 288 : 2981 ? 2997 12479763
198 Psaty BM Lumley T Furberg CD Schellenbaum G Pahor M Alderman MH Weiss NS : Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis . JAMA 2003 ; 289 : 2534 ? 2544 12759325
199 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy: Heart Outcomes Prevention Evaluation Study Investigators . Lancet 2000 ; 355 : 253 ? 259 10675071
200 Pfeffer MA Swedberg K Granger CB Held P McMurray JJ Michelson EL Olofsson B Ostergren J Yusuf S Pocock S : CHARM Investigators and Committees Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme . Lancet 2003 ; 362 : 759 ? 766 13678868
201 Granger CB McMurray JJ Yusuf S Held P Michelson EL Olofsson B Ostergren J Pfeffer MA Swedberg K : CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial . Lancet 2003 ; 362 : 772 ? 776 13678870
202 McMurray JJ Ostergren J Swedberg K Granger CB Held P Michelson EL Olofsson B Yusuf S Pfeffer MA : CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial . Lancet 2003 ; 362 : 767 ? 771 13678869
203 Lindholm LH Ibsen H Dahlof B Devereux RB Beevers G de Faire U Fyhrquist F Julius S Kjeldsen SE Kristiansson K Lederballe-Pedersen O Nieminen MS Omvik P Oparil S Wedel H Aurup P Edelman J Snapinn S : LIFE Study Group Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol . Lancet 2002 ; 359 : 1004 ? 1010 11937179
204 Berl T Hunsicker LG Lewis JB Pfeffer MA Porush JG Rouleau JL Drury PL Esmatjes E Hricik D Parikh CR Raz I Vanhille P Wiegmann TB Wolfe BM Locatelli F Goldhaber SZ Lewis EJ : Irbesartan Diabetic Nephropathy Trial Collaborative Study Group. Collaborative Study Group. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy . Ann Intern Med 2003 ; 138 : 542 ? 549 12667024
205 Laffel LM McGill JB Gans DJ : The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group . Am J Med 1995 ; 99 : 497 ? 504 7485207
206 Bakris GL Williams M Dworkin L Elliott WJ Epstein M Toto R Tuttle K Douglas J Hsueh W Sowers J : Preserving renal function in adults with hypertension and diabetes: a consensus approach: National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group . Am J Kidney Dis 2000 ; 36 : 646 ? 661 10977801
207 Psaty BM Smith NL Siscovick DS Koepsell TD Weiss NS Heckbert SR Lemaitre RN Wagner EH Furberg CD : Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis . JAMA 1997 ; 277 : 739 ? 745 9042847
208 Patel A : ADVANCE Collaborative Group MacMahon S Chalmers J Neal B Woodward M Billot L Harrap S Poulter N Marre M Cooper M Glasziou P Grobbee DE Hamet P Heller S Liu LS Mancia G Mogensen CE Pan CY Rodgers A Williams B : Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial . Lancet 2007 ; 370 : 829 ? 840 17765963
209 Sibai BM : Treatment of hypertension in pregnant women . N Engl J Med 1996 ; 335 : 257 ? 265 8657243
210 Baigent C Keech A Kearney PM Blackwell L Buck G Pollicino C Kirby A Sourjina T Peto R Collins R Simes R : Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins . Lancet 2005 ; 366 : 1267 ? 1278 16214597
211 Py?rala K Pedersen TR Kjekshus J Faergeman O Olsson AG Thorgeirsson G : Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) . Diabetes Care 1997 ; 20 : 614 ? 620 9096989
212 Collins R Armitage J Parish S Sleigh P Peto R : Heart Protection Study Collaborative Group : MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial . Lancet 2003 ; 361 : 2005 ? 2016 12814710
213 Goldberg RB Mellies MJ Sacks FM Moye LA Howard BV Howard WJ Davis BR Cole TG Pfeffer MA Braunwald E : Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators . Circulation 1998 ; 98 : 2513 ? 2519 9843456
214 Shepherd J Barter P Carmena R Deedwania P Fruchart JC Haffner S Hsia J Breazna A LaRosa J Grundy S Waters D : Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study . Diabetes Care 2006 ; 29 : 1220 ? 1226 16731999
215 Sever PS Poulter NR Dahlof B Wedel H Collins R Beevers G Caulfield M Kjeldsen SE Kristinsson A McInnes GT Mehlsen J Nieminen M O'Brien E Ostergren J : Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial?lipid-lowering arm (ASCOT-LLA) . Diabetes Care 2005 ; 28 : 1151 ? 1157 15855581
216 Knopp RH d'Emden M Smilde JG Pocock SJ : Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN) . Diabetes Care 2006 ; 29 : 1478 ? 1485 16801565
217 Singh IM Shishehbor MH Ansell BJ : High-density lipoprotein as a therapeutic target: a systematic review . JAMA 2007 ; 298 : 786 ? 798 17699012
218 Canner PL Berge KG Wenger NK Stamler J Friedman L Prineas RJ Friedewald W : Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin . J Am Coll Cardiol 1986 ; 8 : 1245 ? 1255 3782631
219 Rubins HB Robins SJ Collins D Fye CL Anderson JW Elam MB Faas FH Linares E Schaefer EJ Schectman G Wilt TJ Wittes J : Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group . N Engl J Med 1999 ; 341 : 410 ? 418 10438259
220 Frick MH Elo O Haapa K Heinonen OP Heinsalmi P Helo P Huttunen JK Kaitaniemi P Koskinen P Manninen V : Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease . N Engl J Med 1987 ; 317 : 1237 ? 1245 3313041
221 Keech A Simes RJ Barter P Best J Scott R Taskinen MR Forder P Pillai A Davis T Glasziou P Drury P Kesaniemi YA Sullivan D Hunt D Colman P d'Emden M Whiting M Ehnholm C Laakso M : FIELD study investigators Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial . Lancet 2005 ; 366 : 1849 ? 1861 16310551
222 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults : Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) . JAMA 2001 ; 285 : 2486 ? 2497 11368702
223 Hayward RA Hofer TP Vijan S : Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem . Ann Intern Med 2006 ; 145 : 520 ? 530 17015870
224 Cannon CP Braunwald E McCabe CH Rader DJ Rouleau JL Belder R Joyal SV Hill KA Pfeffer MA Skene AM : Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes . N Engl J Med 2004 ; 350 : 1495 ? 1504 15007110
225 de Lemos JA Blazing MA Wiviott SD Lewis EF Fox KA White HD Rouleau JL Pedersen TR Gardner LH Mukherjee R Ramsey KE Palmisano J Bilheimer DW Pfeffer MA Califf RM Braunwald E : A to Z Investigators Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial . JAMA 2004 ; 292 : 1307 ? 1316 15337732
226 Nissen SE Tuzcu EM Schoenhagen P Brown BG Ganz P Vogel RA Crowe T Howard G Cooper CJ Brodie B Grines CL DeMaria AN : REVERSAL Investigators Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial . JAMA 2004 ; 291 : 1071 ? 1080 14996776
227 Grundy SM Cleeman JI Merz CN Brewer HB Jr Clark LT Hunninghake DB Pasternak RC Smith SC Jr Stone NJ : National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines . Circulation 2004 ; 110 : 227 ? 239 15249516
228 Chasman DI Posada D Subrahmanyan L Cook NR Stanton VP Jr Ridker PM : Pharmacogenetic study of statin therapy and cholesterol reduction . JAMA 2004 ; 291 : 2821 ? 2827 15199031
229 Baigent C Keech A Kearney PM Blackwell L Buck G Pollicino C Kirby A Sourjina T Peto R Collins R Simes R : Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins . Lancet 2005 ; 366 : 1267 ? 1278 16214597
230 Elam MB Hunninghake DB Davis KB Garg R Johnson C Egan D Kostis JB Sheps DS Brinton EA : Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial . JAMA 2000 ; 284 : 1263 ? 1270 10979113
231 Grundy SM Vega GL McGovern ME Tulloch BR Kendall DM Fitz-Patrick D Ganda OP Rosenson RS Buse JB Robertson DD Sheehan JP : Diabetes Multicenter Research Group Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial . Arch Intern Med 2002 ; 162 : 1568 ? 1576 12123399
232 Jones PH Davidson MH : Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin . Am J Cardiol 2005 ; 95 : 120 ? 122 15619408
233 Brunzell JD Davidson M Furberg CD Goldberg RB Howard BV Stein JH Witztum JL : American Diabetes Association, American College of Cardiology Foundation Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation . Diabetes Care 2008 ; 31 : 811 ? 822 18375431
234 Colhoun HM Betteridge DJ Durrington PN Hitman GA Neil HA Livingstone SJ Thomason MJ Mackness MI Charlton-Menys V Fuller JH : CARDS investigators Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial . Lancet 2004 ; 364 : 685 ? 696 15325833
235 Buse JB Ginsberg HN Bakris GL Clark NG Costa F Eckel R Fonseca V Gerstein HC Grundy S Nesto RW Pignone MP Plutzky J Porte D Redberg R Stitzel KF Stone NJ : American Heart Association, American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association . Diabetes Care 2007 ; 30 : 162 ? 172 17192355
236 Antithrombotic Trialists' (ATT) Collaboration Baigent C Blackwell L Collins R Emberson J Godwin J Peto R Buring J Hennekens C Kearney P Meade T Patrono C Roncaglioni MC Zanchetti A : Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials . Lancet 2009 ; 373 : 1849 ? 1860 19482214
237 Wolff T Miller T Ko S : Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force . Ann Intern Med 2009 ; 150 : 405 ? 410 19293073
238 US Preventive Services Task Force : Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement . Ann Intern Med 2009 ; 150 : 396 ? 404 19293072
239 Ogawa H Nakayama M Morimoto T Uemura S Kanauchi M Doi N Jinnouchi H Sugiyama S Saito Y : Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial . JAMA 2008 ; 300 : 2134 ? 2141 18997198
240 Belch J MacCuish A Campbell I Cobbe S Taylor R Prescott R Lee R Bancroft J MacEwan S Shepherd J Macfarlane P Morris A Jung R Kelly C Connacher A Peden N Jamieson A Matthews D Leese G McKnight J O'Brien I Semple C Petrie J Gordon D Pringle S MacWalter R : The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease . BMJ 2008 ; 337 : a1840 18927173
241 Pignone M Earnshaw S Tice JA Pletcher MJ : Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis . Ann Intern Med 2006 ; 144 : 326 ? 336 16520473
242 Campbell CL Smyth S Montalescot G Steinhubl SR : Aspirin dose for the prevention of cardiovascular disease: a systematic review . JAMA 2007 ; 297 : 2018 ? 2024 17488967
243 Davi G Patrono C : Platelet activation and atherothrombosis . N Engl J Med 2007 ; 357 : 2482 ? 2494 18077812
244 Watala C Golanski J Pluta J Boncler M Rozalski M Luzak B Kropiwnicka A Drzewoski J : Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control . Thromb Res 2004 ; 113 : 101 ? 113 15115665
245 Lev EI : Aspirin resistance transient laboratory finding or important clinical entity? J Am Coll Cardiol 2009 ; 53 : 678 ? 680 19232900
246 Santilli F Rocca B De Cristofaro R Lattanzio S Pietrangelo L Habib A Pettinella C Recchiuti A Ferrante E Ciabattoni G Davi G Patrono C : Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin “resistance” . J Am Coll Cardiol 2009 ; 53 : 667 ? 677 19232899
247 Bhatt DL Marso SP Hirsch AT Ringleb PA Hacke W Topol EJ : Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus . Am J Cardiol 2002 ; 90 : 625 ? 628 12231089
248 Haire-Joshu D Glasgow RE Tibbs TL : Smoking and diabetes . Diabetes Care 1999 ; 22 : 1887 ? 1898 10546025
249 American Diabetes Asociation : Smoking and diabetes (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S74 ? S75 14693932
250 US Preventive Services Task Force Counseling to Prevent Tobacco Use and Tobacco-Related Diseases: Recommendation Statement . Rockville, MD , Agency for Healthcare Research and Quality , 2003
251 Ranney L Melvin C Lux L McClain E Lohr KN : Systematic review: smoking cessation intervention strategies for adults and adults in special populations . Ann Intern Med 2006 ; 145 : 845 ? 856 16954352
252 Scognamiglio R Negut C Ramondo A Tiengo A Avogaro A : Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus . J Am Coll Cardiol 2006 ; 47 : 65 ? 71 16386666
253 Boden WE O'Rourke RA Teo KK Hartigan PM Maron DJ Kostuk WJ Knudtson M Dada M Casperson P Harris CL Chaitman BR Shaw L Gosselin G Nawaz S Title LM Gau G Blaustein AS Booth DC Bates ER Spertus JA Berman DS Mancini GB Weintraub WS : COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease . N Engl J Med 2007 ; 356 : 1503 ? 1516 17387127
254 BARI 2D Study Group Frye RL August P Brooks MM Hardison RM Kelsey SF MacGregor JM Orchard TJ Chaitman BR Genuth SM Goldberg SH Hlatky MA Jones TL Molitch ME Nesto RW Sako EY Sobel BE : A randomized trial of therapies for type 2 diabetes and coronary artery disease . N Engl J Med 2009 ; 360 : 2503 ? 2515 19502645
255 Wackers FJ Chyun DA Young LH Heller GV Iskandrian AE Davey JA Barrett EJ Taillefer R Wittlin SD Filipchuk N Ratner RE Inzucchi SE : Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes mellitus in the DIAD Study . Diabetes Care 2007 ; 30 : 2892 ? 2898 17682123
256 Young LH Wackers FJ Chyun DA Davey JA Barrett EJ Taillefer R Heller GV Iskandrian AE Wittlin SD Filipchuk N Ratner RE Inzucchi SE : DIAD Investigators Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial . JAMA 2009 ; 301 : 1547 ? 1555 19366774
257 Braunwald E Domanski MJ Fowler SE Geller NL Gersh BJ Hsia J Pfeffer MA Rice MM Rosenberg YD Rouleau JL : PEACE Trial Investigators Angiotensin-converting-enzyme inhibition in stable coronary artery disease . N Engl J Med 2004 ; 351 : 2058 ? 2068 15531767
258 Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial . Lancet 2008 ; 372 : 1174 ? 1183 18757085
259 Garg JP Bakris GL : Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease . Vasc Med 2002 ; 7 : 35 ? 43 12083733
260 Klausen K Borch-Johnsen K Feldt-Rasmussen B Jensen G Clausen P Scharling H Appleyard M Jensen JS : Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes . Circulation 2004 ; 110 : 32 ? 35 15210602
261 Gall MA Hougaard P Borch-Johnsen K Parving HH : Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study . BMJ 1997 ; 314 : 783 ? 788 9080995
262 Ravid M Lang R Rachmani R Lishner M : Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study . Arch Intern Med 1996 ; 156 : 286 ? 289 8572838
263 Reichard P Nilsson BY Rosenqvist U : The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus . N Engl J Med 1993 ; 329 : 304 ? 309 8147960
264 Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group . Kidney Int 1995 ; 47 : 1703 ? 1720 7643540
265 Lewis EJ Hunsicker LG Bain RP Rohde RD : The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group . N Engl J Med 1993 ; 329 : 1456 ? 1462 8413456
266 Remuzzi G Macia M Ruggenenti P : Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study . JAmSocNephrol 2006 ; 17 : S90 ? S97
267 Bilous R Chaturvedi N Sjølie AK Fuller J Klein R Orchard T Porta M Parving HH : Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials . Ann Intern Med 2009 ; 151 : 11 ? 14 19451554
268 Mauer M Zinman B Gardiner R Suissa S Sinaiko A Strand T Drummond K Donnelly S Goodyer P Gubler MC Klein R : Renal and retinal effects of enalapril and losartan in type 1 diabetes . N Engl J Med 2009 ; 361 : 40 ? 51 19571282
269 Lewis EJ Hunsicker LG Clarke WR Berl T Pohl MA Lewis JB Ritz E Atkins RC Rohde R Raz I : Collaborative Study Group Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes . N Engl J Med 2001 ; 345 : 851 ? 860 11565517
270 Brenner BM Cooper ME de Zeeuw D Keane WF Mitch WE Parving HH Remuzzi G Snapinn SM Zhang Z Shahinfar S : RENAAL Study Investigators Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy . N Engl J Med 2001 ; 345 : 861 ? 869 11565518
271 Parving HH Lehnert H Brochner-Mortensen J Gomis R Andersen S Arner P : Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes . N Engl J Med 2001 ; 345 : 870 ? 878 11565519
272 Pepine CJ Handberg EM Cooper-DeHoff RM Marks RG Kowey P Messerli FH Mancia G Cangiano JL Garcia-Barreto D Keltai M Erdine S Bristol HA Kolb HR Bakris GL Cohen JD Parmley WW : INVEST Investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril study (INVEST): a randomized controlled trial . JAMA 2003 ; 290 : 2805 ? 2816 14657064
273 Bakris GL Siomos M Richardson D Janssen I Bolton WK Hebert L Agarwal R Catanzaro D : ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group . Kidney Int 2000 ; 58 : 2084 ? 2092 11044229
274 Mogensen CE Neldam S Tikkanen I Oren S Viskoper R Watts RW Cooper ME : Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study . BMJ 2000 ; 321 : 1440 ? 1444 11110735
275 Schjoedt KJ Jacobsen P Rossing K Boomsma F Parving HH : Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone . Horm Metab Res 2005 ; 37 ( Suppl. 1 ): 4 ? 8 15918104
276 Schjoedt KJ Rossing K Juhl TR Boomsma F Rossing P Tarnow L Parving HH : Beneficial impact of spironolactone in diabetic nephropathy . Kidney Int 2005 ; 68 : 2829 ? 2836 16316360
277 Parving HH Persson F Lewis JB Lewis EJ Hollenberg NK : AVOID Study Investigators Aliskiren combined with losartan in type 2 diabetes and nephropathy . N Engl J Med 2008 ; 358 : 2433 ? 2446 18525041
278 Pijls LT de Vries H Donker AJ van Eijk JT : The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial . Nephrol Dial Transplant 1999 ; 14 : 1445 ? 1453 10383006
279 Pedrini MT Levey AS Lau J Chalmers TC Wang PH : The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis . Ann Intern Med 1996 ; 124 : 627 ? 632 8607590
280 Hansen HP Tauber-Lassen E Jensen BR Parving HH : Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy . Kidney Int 2002 ; 62 : 220 ? 228 12081581
281 Kasiske BL Lakatua JD Ma JZ Louis TA : A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function . Am J Kidney Dis 1998 ; 31 : 954 ? 961 9631839
282 Eknoyan G Hostetter T Bakris GL Hebert L Levey AS Parving HH Steffes MW Toto R : Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK) . Am J Kidney Dis 2003 ; 42 : 617 ? 622 14520612
283 Levey AS Coresh J Balk E Kausz AT Levin A Steffes MW Hogg RJ Perrone RD Lau J Eknoyan G : National Kidney Foundation National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification . Ann Intern Med 2003 ; 139 : 137 ? 147 12859163
284 Kramer H Molitch ME : Screening for kidney disease in adults with diabetes . Diabetes Care 2005 ; 28 : 1813 ? 1816 15983346
285 Kramer HJ Nguyen QD Curhan G Hsu CY : Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus . JAMA 2003 ; 289 : 3273 ? 3277 12824208
286 Tsalamandris C Allen TJ Gilbert RE Sinha A Panagiotopoulos S Cooper ME Jerums G : Progressive decline in renal function in diabetic patients with and without albuminuria . Diabetes 1994 ; 43 : 649 ? 655 8168641
287 Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D : A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group . Ann Intern Med 1999 ; 130 : 461 ? 470 10075613
288 Rigalleau V Lasseur C Perlemoine C Barthe N Raffaitin C Liu C Chauveau P Baillet-Blanco L Beauvieux MC Combe C Gin H : Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? Diabetes Care 2005 ; 28 : 838 ? 843 15793182
289 Levinsky NG : Specialist evaluation in chronic kidney disease: too little, too late . Ann Intern Med 2002 ; 137 : 542 ? 543 12230357
290 American Diabetes Association : Nephropathy in diabetes (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S79 ? S83 14693934
291 Klein R : Hyperglycemia and microvascular and macrovascular disease in diabetes . Diabetes Care 1995 ; 18 : 258 ? 268 7729308
292 Estacio RO McFarling E Biggerstaff S Jeffers BW Johnson D Schrier RW : Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM . Am J Kidney Dis 1998 ; 31 : 947 ? 953 9631838
293 Leske MC Wu SY Hennis A Hyman L Nemesure B Yang L Schachat AP : Barbados Eye Study Group Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies . Ophthalmology 2005 ; 112 : 799 ? 805 15878059
294 Fong DS Aiello LP Ferris FL 3rd Klein R : Diabetic retinopathy . Diabetes Care 2004 ; 27 : 2540 ? 2553 15451934
295 Diabetes Control and Complications Trial Research Group : Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group . Diabetes Care 2000 ; 23 : 1084 ? 1091 10937502
296 The Diabetic Retinopathy Study (DRS) Research Group Preliminary report on the effects of photocoagulation therapy: DRS Report #1 . Am J Ophthalmol 1976 ; 81 : 383 ? 396 944535
297 Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group . Arch Ophthalmol 1985 ; 103 : 1796 ? 1806 2866759
298 Klein R Klein BE Moss SE Davis MD DeMets DL : The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years . Arch Ophthalmol 1984 ; 102 : 520 ? 526 6367724
299 Harris MI Klein R Welborn TA Knuiman MW : Onset of NIDDM occurs at least 4?7 yr before clinical diagnosis . Diabetes Care 1992 ; 15 : 815 ? 819 1516497
300 Vijan S Hofer TP Hayward RA : Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus . JAMA 2000 ; 283 : 889 ? 896 10685713
301 Klein R : Screening interval for retinopathy in type 2 diabetes . Lancet 2003 ; 361 : 190 ? 191 12547536
302 Younis N Broadbent DM Vora JP Harding SP : Liverpool Diabetic Eye Study Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study . Lancet 2003 ; 361 : 195 ? 200 12547541
303 Ahmed J Ward TP Bursell SE Aiello LM Cavallerano JD Vigersky RA : The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy . Diabetes Care 2006 ; 29 : 2205 ? 2209 17003294
304 American Diabetes Association : Retinopathy in diabetes . Diabetes Care 2004 ; 27 Suppl. 1 : S84 ? S87 14693935
305 Ciulla TA Amador AG Zinman B : Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies . Diabetes Care 2003 ; 26 : 2653 ? 2664 12941734
306 Boulton AJ Vinik AI Arezzo JC Bril V Feldman EL Freeman R Malik RA Maser RE Sosenko JM Ziegler D : American Diabetes Association Diabetic neuropathies: a statement by the American Diabetes Association . Diabetes Care 2005 ; 28 : 956 ? 962 15793206
307 Vinik AI Maser RE Mitchell BD Freeman R : Diabetic autonomic neuropathy . Diabetes Care 2003 ; 26 : 1553 ? 1579 12716821
308 Boulton AJ Armstrong DG Albert SF Frykberg RG Hellman R Kirkman MS Lavery LA Lemaster JW Mills JL Sr Mueller MJ Sheehan P Wukich DK : American Diabetes Association, American Association of Clinical Endocrinologists Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists . Diabetes Care 2008 ; 31 : 1679 ? 1685 18663232
309 American Diabetes Association : Peripheral arterial disease in people with diabetes (Consensus Statement) . Diabetes Care 2003 ; 26 : 3333 ? 3341 14633825
310 American Diabetes Association : Consensus Development Conference on Diabetic Foot Wound Care, 7?8 April 1999, Boston, Massachusetts . Diabetes Care 1999 ; 22 : 1354 ? 1360 10480782
311 Silverstein J Klingensmith G Copeland KC Plotnick L Kaufman F Laffel L Deeb LC Grey M Anderson BJ Holzmeister LA Clark NG : Care of children and adolescents with type 1 diabetes mellitus: A statement of the American Diabetes Association . Diabetes Care 2005 ; 28 : 186 ? 212 15616254
312 Northam EA Anderson PJ Werther GA Warne GL Adler RG Andrewes D : Neuropsychological complications of IDDM in children 2 years after disease onset . Diabetes Care 1998 ; 21 : 379 ? 384 9540019
313 Rovet J Alvarez M : Attentional functioning in children and adolescents with IDDM . Diabetes Care 1997 ; 20 : 803 ? 810 9135946
314 Bjørgaas M Gimse R Vik T Sand T : Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia . Acta Paediatr 1997 ; 86 : 148 ? 153 9055883
315 Doyle EA Weinzimer SA Steffen AT Ahern JA Vincent M Tamborlane WV : A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine . Diabetes Care 2004 ; 27 : 1554 ? 1558 15220227
316 Nimri R Weintrob N Benzaquen H Ofan R Fayman G Phillip M : Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study . Pediatrics 2006 ; 117 : 2126 ? 2131 16740856
317 Krantz JS Mack WJ Hodis HN Liu CR Liu CH Kaufman FR : Early onset of subclinical atherosclerosis in young persons with type 1 diabetes . J Pediatr 2004 ; 145 : 452 ? 457 15480366
318 Jarvisalo MJ Putto-Laurila A Jartti L Lehtimaki T Solakivi T Ronnemaa T Raitakari OT : Carotid artery intima-media thickness in children with type 1 diabetes . Diabetes 2002 ; 51 : 493 ? 498 11812760
319 Haller MJ Samyn M Nichols WW Brusko T Wasserfall C Schwartz RF Atkinson M Shuster JJ Pierce GL Silverstein JH : Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes . Diabetes Care 2004 ; 27 : 2911 ? 2917 15562206
320 Orchard TJ Forrest KY Kuller LH Becker DJ : Pittsburgh Epidemiology of Diabetes Complications Study Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study . Diabetes Care 2001 ; 24 : 1053 ? 1059 11375370
321 Kavey RE Allada V Daniels SR Hayman LL McCrindle BW Newburger JW Parekh RS Steinberger J : American Heart Association Expert Panel on Population and Prevention Science, American Heart Association Council on Cardiovascular Disease in the Young, American Heart Association Council on Epidemiology and Prevention, American Heart Association Council on Nutrition, Physical Activity and Metabolism, American Heart Association Council on High Blood Pressure Research, American Heart Association Council on Cardiovascular Nursing, American Heart Association Council on the Kidney in Heart Disease, Interdisciplinary Working Group on Quality of Care and Outcomes Research Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics . Circulation 2006 ; 114 : 2710 ? 2738 17130340
322 McCrindle BW Urbina EM Dennison BA Jacobson MS Steinberger J Rocchini AP Hayman LL Daniels SR : American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, American Heart Association Council of Cardiovascular Disease in the Young, American Heart Association Council on Cardiovascular Nursing Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing . Circulation 2007 ; 115 : 1948 ? 1967 17377073
323 Salo P Viikari J Hamalainen M Lapinleimu H Routi T Ronnemaa T Seppanen R Jokinen E Valimaki I Simell O : Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet: the STRIP baby project. Special Turku coronary Risk factor Intervention Project for children . Acta Paediatr 1999 ; 88 : 505 ? 512 10426172
324 Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC) . The Writing Group for the DISC Collaborative Research Group JAMA 1995 ; 273 : 1429 ? 1435 7723156
325 McCrindle BW Ose L Marais AD : Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial . J Pediatr 2003 ; 143 : 74 ? 80 12915827
326 de Jongh S Lilien MR op't RJ Stroes ES Bakker HD Kastelein JJ : Early statin therapy restores endothelial function in children with familial hypercholesterolemia . J Am Coll Cardiol 2002 ; 40 : 2117 ? 2121 12505222
327 Wiegman A Hutten BA de Groot E Rodenburg J Bakker HD Buller HR Sijbrands EJ Kastelein JJ : Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial . JAMA 2004 ; 292 : 331 ? 337 15265847
328 Holmes GK : Screening for coeliac disease in type 1 diabetes . Arch Dis Child 2002 ; 87 : 495 ? 498 12456547
329 Rewers M Liu E Simmons J Redondo MJ Hoffenberg EJ : Celiac disease associated with type 1 diabetes mellitus . Endocrinol Metab Clin North Am 2004 ; 33 : 197 ? 214 , xi 15053903
330 Roldan MB Alonso M Barrio R : Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus . Diabetes Nutr Metab 1999 ; 12 : 27 ? 31 10517303
331 Kordonouri O Deiss D Danne T Dorow A Bassir C Gruters-Kieslich A : Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes . Diabet Med 2002 ; 19 : 518 ? 521 12060066
332 Mohn A Di Michele S Di Luzio R Tumini S Chiarelli F : The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus . Diabet Med 2002 ; 19 : 70 ? 73 11869306
333 Chase HP Garg SK Cockerham RS Wilcox WD Walravens PA : Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes . Diabet Med 1990 ; 7 : 299 ? 303 2140081
334 Eppens MC Craig ME Cusumano J Hing S Chan AK Howard NJ Silink M Donaghue KC : Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes . Diabetes Care 2006 ; 29 : 1300 ? 1306 16732012
335 Kitzmiller JL Gavin LA Gin GD Jovanovic-Peterson L Main EK Zigrang WD : Preconception care of diabetes. Glycemic control prevents congenital anomalies . JAMA 1991 ; 265 : 731 ? 736 1990188
336 Goldman JA Dicker D Feldberg D Yeshaya A Samuel N Karp M : Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study . AmJ Obstet Gynecol 1986 ; 155 : 293 ? 297 3740144
337 Rosenn B Miodovnik M Combs CA Khoury J Siddiqi TA : Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome . Obstet Gynecol 1991 ; 77 : 846 ? 849 2030855
338 Tchobroutsky C Vray MM Altman JJ : Risk/benefit ratio of changing late obstetrical strategies in the management of insulin-dependent diabetic pregnancies. A comparison between 1971?1977 and 1978?1985 periods in 389 pregnancies . Diabete Metab 1991 ; 17 : 287 ? 294 1864436
339 Willhoite MB Bennert HW Jr Palomaki GE Zaremba MM Herman WH Williams JR Spear NH : The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program . Diabetes Care 1993 ; 16 : 450 ? 455 8432216
340 Cooper WO Hernandez-Diaz S Arbogast PG Dudley JA Dyer S Gideon PS Hall K Ray WA : Major congenital malformations after first-trimester exposure to ACE inhibitors . N Engl J Med 2006 ; 354 : 2443 ? 2451 16760444
341 American Diabetes Association : Preconception care of women with diabetes (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S76 ? S78 14693933
342 Brown AF Mangione CM Saliba D Sarkisian CA : California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes Guidelines for improving the care of the older person with diabetes mellitus . J Am Geriatr Soc 2003 ; 51 : S265 ? S280 12694461
343 Curb JD Pressel SL Cutler JA Savage PJ Applegate WB Black H Camel G Davis BR Frost PH Gonzalez N Guthrie G Oberman A Rutan GH Stamler J : Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension . Systolic Hypertension in the Elderly Program Cooperative Research Group JAMA 1996 ; 276 : 1886 ? 1892 8968014
344 Beckett NS Peters R Fletcher AE Staessen JA Liu L Dumitrascu D Stoyanovsky V Antikainen RL Nikitin Y Anderson C Belhani A Forette F Rajkumar C Thijs L Banya W Bulpitt CJ : HYVET Study Group Treatment of hypertension in patients 80 years of age or older . N Engl J Med 2008 ; 358 : 1887 ? 1898 18378519
345 Clement S Braithwaite SS Magee MF Ahmann A Smith EP Schafer RG Hirsch IB Hirsh IB : American Diabetes Association Diabetes in Hospitals Writing Committee Management of diabetes and hyperglycemia in hospitals . Diabetes Care 2004 ; 27 : 553 ? 591 14747243
346 Moghissi ES Korytkowski MT DiNardo M Einhorn D Hellman R Hirsch IB Inzucchi SE Ismail-Beigi F Kirkman MS Umpierrez GE : American Association of Clinical Endocrinologists, American Diabetes Association American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control . Diabetes Care 2009 ; 32 : 1119 ? 1131 19429873
347 American Diabetes Association : Economic costs of diabetes in the U.S. In 2007 . Diabetes Care 2008 ; 31 : 596 ? 615 18308683
348 Centers for Disease Control and Prevention National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007 . Atlanta, GA , US Department of Health and Human Services , 2008
349 Levetan CS Passaro M Jablonski K Kass M Ratner RE : Unrecognized diabetes among hospitalized patients . Diabetes Care 1998 ; 21 : 246 ? 249 9539990
350 Umpierrez GE Isaacs SD Bazargan N You X Thaler LM Kitabchi AE : Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes . J Clin Endocrinol Metab 2002 ; 87 : 978 ? 982 11889147
351 van den Berghe G Wouters P Weekers F Verwaest C Bruyninckx F Schetz M Vlasselaers D Ferdinande P Lauwers P Bouillon R : Intensive insulin therapy in the critically ill patients . N Engl J Med 2001 ; 345 : 1359 ? 1367 11794168
352 Malmberg K Norhammar A Wedel H Ryden L : Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study . Circulation 1999 ; 99 : 2626 ? 2632 10338454
353 Wiener RS Wiener DC Larson RJ : Benefits and risks of tight glucose control in critically ill adults: a meta-analysis . JAMA 2008 ; 300 : 933 ? 944 18728267
354 Brunkhorst FM Engel C Bloos F Meier-Hellmann A Ragaller M Weiler N Moerer O Gruendling M Oppert M Grond S Olthoff D Jaschinski U John S Rossaint R Welte T Schaefer M Kern P Kuhnt E Kiehntopf M Hartog C Natanson C Loeffler M Reinhart K : German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis . N Engl J Med 2008 ; 358 : 125 ? 139 18184958
355 NICE-SUGAR Study Investigators Finfer S Chittock DR Su SY Blair D Foster D Dhingra V Bellomo R Cook D Dodek P Henderson WR Hebert PC Heritier S Heyland DK McArthur C McDonald E Mitchell I Myburgh JA Norton R Potter J Robinson BG Ronco JJ : Intensive versus conventional glucose control in critically ill patients . N Engl J Med 2009 ; 360 : 1283 ? 1297 19318384
356 Krinsley JS Grover A : Severe hypoglycemia in critically ill patients: risk factors and outcomes . Crit Care Med 2007 ; 35 : 2262 ? 2267 17717490
357 Van den Berghe G Wilmer A Hermans G Meersseman W Wouters PJ Milants I Van Wijngaerden E Bobbaers H Bouillon R : Intensive insulin therapy in the medical ICU . N Engl J Med 2006 ; 354 : 449 ? 461 16452557
358 Griesdale DE de Souza RJ van Dam RM Heyland DK Cook DJ Malhotra A Dhaliwal R Henderson WR Chittock DR Finfer S Talmor D : Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data . CMAJ 2009 ; 180 : 821 ? 827 19318387
359 Saudek CD Herman WH Sacks DB Bergenstal RM Edelman D Davidson MB : A new look at screening and diagnosing diabetes mellitus . J Clin Endocrinol Metab 2008 ; 93 : 2447 ? 2453 18460560
360 Mitrakou A Ryan C Veneman T Mokan M Jenssen T Kiss I Durrant J Cryer P Gerich J : Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction . Am J Physiol 1991 ; 260 : E67 ? E74 1987794
361 Korytkowski M DiNardo M Donihi AC Bigi L Devita M : Evolution of a diabetes inpatient safety committee . Endocr Pract 2006 ; 12 ( Suppl. 3 ): 91 ? 99 16905524
362 DiNardo M Noschese M Korytkowski M Freeman S : The medical emergency team and rapid response system: finding, treating, and preventing hypoglycemia . Jt Comm J Qual Patient Saf 2006 ; 32 : 591 ? 595 17066997
363 Donihi AC Raval D Saul M Korytkowski MT DeVita MA : Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients . Endocr Pract 2006 ; 12 : 358 ? 362 16901792
364 Goldberg PA Siegel MD Sherwin RS Halickman JI Lee M Bailey VA Lee SL Dziura JD Inzucchi SE : Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit . Diabetes Care 2004 ; 27 : 461 ? 467 14747229
365 Rea RS Donihi AC Bobeck M Herout P McKaveney TP Kane-Gill SL Korytkowski MT : Implementing an intravenous insulin infusion protocol in the intensive care unit . Am J Health Syst Pharm 2007 ; 64 : 385 ? 395 17299178
366 Nazer LH Chow SL Moghissi ES : Insulin infusion protocols for critically ill patients: a highlight of differences and similarities . Endocr Pract 2007 ; 13 : 137 ? 146 17490927
367 DeSantis AJ Schmeltz LR Schmidt K O'Shea-Mahler E Rhee C Wells A Brandt S Peterson S Molitch ME : Inpatient management of hyperglycemia: the Northwestern experience . Endocr Pract 2006 ; 12 : 491 ? 505 17002924
368 Noschese M Donihi AC Koerbel G Karslioglu E DiNardo M Curll M Korytkowski MT : Effect of a diabetes order set on glycaemic management and control in the hospital . Qual Saf Health Care 2008 ; 17 : 464 ? 468 19064664
369 Umpierrez GE Hor T Smiley D Temponi A Umpierrez D Ceron M Munoz C Newton C Peng L Baldwin D : Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes . J Clin Endocrinol Metab 2009 ; 94 : 564 ? 569 19017758
370 Moghissi ES Hirsch IB : Hospital management of diabetes . Endocrinol Metab Clin North Am 2005 ; 34 : 99 ? 116 15752924
371 Umpierrez GE Smiley D Zisman A Prieto LM Palacio A Ceron M Puig A Mejia R : Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial) . Diabetes Care 2007 ; 30 : 2181 ? 2186 17513708
372 Umpierrez GE Palacio A Smiley D : Sliding scale insulin use: myth or insanity? Am J Med 2007 ; 120 : 563 ? 567 17602924
373 Queale WS Seidler AJ Brancati FL : Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus . Arch Intern Med 1997 ; 157 : 545 ? 552 9066459
374 Korytkowski MT Salata RJ Koerbel GL Selzer F Karslioglu E Idriss AM Lee KK Moser AJ Toledo FG : Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial . Diabetes Care 2009 ; 32 : 594 ? 596 19336639
375 Hirsch IB : Sliding scale insulin?time to stop sliding . JAMA 2009 ; 301 : 213 ? 214 19141770
376 Umpierrez GE : Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy . Diabetes Care 2009 ; 32 : 751 ? 753 19336641
377 Pancorbo-Hidalgo PL Garcia-Fernandez FP Ramirez-Perez C : Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit . J Clin Nurs 2001 ; 10 : 482 ? 490 11822496
378 Nylen ES Muller B : Endocrine changes in critical illness . J Intensive Care Med 2004 ; 19 : 67 ? 82 15070518
379 Shilo S Berezovsky S Friedlander Y Sonnenblick M : Hypoglycemia in hospitalized nondiabetic older patients . J Am Geriatr Soc 1998 ; 46 : 978 ? 982 9706886
380 Fischer KF Lees JA Newman JH : Hypoglycemia in hospitalized patients. Causes and outcomes . N Engl J Med 1986 ; 315 : 1245 ? 1250 3534567
381 Markovitz LJ Wiechmann RJ Harris N Hayden V Cooper J Johnson G Harelstad R Calkins L Braithwaite SS : Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery . Endocr Pract 2002 ; 8 : 10 ? 18 11939754
382 Levetan CS Salas JR Wilets IF Zumoff B : Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes . Am J Med 1995 ; 99 : 22 ? 28 7598138
383 Levetan CS Passaro MD Jablonski KA Ratner RE : Effect of physician specialty on outcomes in diabetic ketoacidosis . Diabetes Care 1999 ; 22 : 1790 ? 1795 10546009
384 Koproski J Pretto Z Poretsky L : Effects of an intervention by a diabetes team in hospitalized patients with diabetes . Diabetes Care 1997 ; 20 : 1553 ? 1555 9314634
385 Furnary AP Braithwaite SS : Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy . Am J Cardiol 2006 ; 98 : 557 ? 564 16893717
386 American Diabetes Association : Diabetes nutrition recommendations for health care institutions (Position Statement) . Diabetes Care 2004 ; 27 ( Suppl. 1 ): S55 ? S57 14693926
387 Boucher JL Swift CS Franz MJ Kulkarni K Schafer RG Pritchett E Clark NG : Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional . J Am Diet Assoc 2007 ; 107 : 105 ? 111 17197277
388 Scott MG Bruns DE Boyd JC Sacks DB : Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem 2009 ; 55 : 18 ? 20 19028817
389 D'Orazio P Burnett RW Fogh-Andersen N Jacobs E Kuwa K Kulpmann WR Larsson L Lewenstam A Maas AH Mager G Naskalski JW Okorodudu AO : International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing Approved IFCC recommendation on reporting results for blood glucose (abbreviated) . Clin Chem 2005 ; 51 : 1573 ? 1576 16120945
390 Dungan K Chapman J Braithwaite SS Buse J : Glucose measurement: confounding issues in setting targets for inpatient management . Diabetes Care 2007 ; 30 : 403 ? 409 17259520
391 Boyd JC Bruns DE : Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose . Clin Chem 2001 ; 47 : 209 ? 214 11159768
392 Goldberg PA Siegel MD Russell RR Sherwin RS Halickman JI Cooper DA Dziura JD Inzucchi SE : Experience with the continuous glucose monitoring system in a medical intensive care unit . Diabetes Technol Ther 2004 ; 6 : 339 ? 347 15198837
393 Cheung BM Ong KL Cherny SS Sham PC Tso AW Lam KS : Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006 . Am J Med 2009 ; 122 : 443 ? 453 19375554
394 Coleman K Austin BT Brach C Wagner EH : Evidence on the Chronic Care Model in the new millennium . Health Aff (Millwood) 2009 ; 28 : 75 ? 85 19124857
395 Clark CM Jr Snyder JW Meek RL Stutz LM Parkin CG : A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction . Diabetes Care 2001 ; 24 : 1079 ? 1086 11375374
396 Meigs JB Cagliero E Dubey A Murphy-Sheehy P Gildesgame C Chueh H Barry MJ Singer DE Nathan DM : A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project . Diabetes Care 2003 ; 26 : 750 ? 757 12610033
397 O'Connor PJ Desai J Solberg LI Reger LA Crain AL Asche SE Pearson TL Clark CK Rush WA Cherney LM Sperl-Hillen JM Bishop DB : Randomized trial of quality improvement intervention to improve diabetes care in primary care settings . Diabetes Care 2005 ; 28 : 1890 ? 1897 16043728
398 Sperl-Hillen JM O'Connor PJ : Factors driving diabetes care improvement in a large medical group: ten years of progress . Am J Manag Care 2005 ; 11 : S177 ? S185 16111440
399 Siminerio LM : Implementing diabetes self-management training programs: breaking through the barriers in primary care . EndocrPract 2006 ; 12 ( Suppl. 1 ): 124 ? 130
400 Mahoney JJ : Reducing patient drug acquisition costs can lower diabetes health claims . Am J Manag Care 2005 ; 11 : S170 ? S176 16111439
401 Maney M Tseng CL Safford MM Miller DR Pogach LM : Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration . Diabetes Care 2007 ; 30 : 245 ? 251 17259489
402 Bergenstal RM : Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes . Endocr Pract 2006 ; 12 ( Suppl. 1 ): 98 ? 104 16627391
403 Berikai P Meyer PM Kazlauskaite R Savoy B Kozik K Fogelfeld L : Gain in patients' knowledge of diabetes management targets is associated with better glycemic control . Diabetes Care 2007 ; 30 : 1587 ? 1589 17372160
404 O'Connor PJ : Electronic medical records and diabetes care improvement: are we waiting for Godot? Diabetes Care 2003 ; 26 : 942 ? 943 12610062
405 Shojania KG Ranji SR McDonald KM Grimshaw JM Sundaram V Rushakoff RJ Owens DK : Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis . JAMA 2006 ; 296 : 427 ? 440 16868301
406 Davidson MB : How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions . Diabetes Care 2009 ; 32 : 370 ? 372 19171736
407 McLean DL McAlister FA Johnson JA King KM Makowsky MJ Jones CA Tsuyuki RT : SCRIP-HTN Investigators A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN) . Arch Intern Med 2008 ; 168 : 2355 ? 2361 19029501
408 Parchman ML Zeber JE Romero RR Pugh JA : Risk of coronary artery disease in type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: a STARNet study . Med Care 2007 ; 45 : 1129 ? 1134 18007162
409 Feifer C Nemeth L Nietert PJ Wessell AM Jenkins RG Roylance L Ornstein SM : Different paths to high-quality care: three archetypes of top-performing practice sites . Ann Fam Med 2007 ; 5 : 233 ? 241 17548851
410 Ornstein S Nietert PJ Jenkins RG Wessell AM Nemeth LS Feifer C Corley ST : Improving diabetes care through a multicomponent quality improvement model in a practice-based research network . Am J Med Qual 2007 ; 22 : 34 ? 41 17227876
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.